We Tested 3 Cleansers - One is Clearly A Goldmine in AU

Three cleansers. Australia's most reviewed. One uncomfortable truth nobody at Chemist Warehouse will tell you. Two of the top 3 facial cleansers Australians buy most are specifically formulated for oily, acne-prone skin — but they're being marketed to everyone. And two of them are secretly owned by the same parent company currently facing 15,000 cancer lawsuits overseas. In this video I pull apart the ingredient lists, trace the parent companies, and cross-reference the clinical data for: CeraVe Hydrating Cleanser ($16.99–$22.99) La Roche-Posay Effaclar Foaming Gel Moussant ($31.99) Avène Cleanance Cleansing Gel ($31.39) I test all three on the same criteria: who the formula is actually designed for, what the ingredients really do, the company behind the brand, and whether the price reflects the formula — or just a very good story. One of these cleansers has independently peer-reviewed clinical evidence behind it. The other two are leaning on "dermatologist tested" — a claim that has no legal definition under Australian consumer law. By the end of this video you will know exactly which cleanser belongs in your bathroom, which one was never made for your skin type, and why the most expensive option on the shelf is not buying you a better formula. ⚠️ DISCLAIMER This content is created primarily for entertainment purposes, with additional informational and educational context. The information presented is based on publicly available sources, research, customer experiences, and commentary. It should not be interpreted as medical, dermatological, legal, or professional advice. Any decisions involving skincare, beauty purchases, health, or personal choices should always be made after conducting your own research and, when appropriate, consulting qualified professionals. --- ⚠️ COPYRIGHT & FAIR USE This video may include images, footage, or excerpts not owned by this channel. Such material is used under the Fair Use doctrine (Section 107 of the U.S. Copyright Act) for purposes including commentary, criticism, reporting, education, and analysis. The use is transformative and adds original commentary and perspective. All rights remain with their respective copyright owners.